Danaher (NYSE: DHR) is one of those stocks that seems unable to do any wrong, and it keeps going up and up while frustrated investors wait for a better entry point for this global healthcare, science, and technology conglomerate.
That past stock performance on its own is not a justification for buying the stock. On the other hand, if you feel confident that there's a high probability the stock will continue to appreciate over time, then why not just buy it?
With these questions in mind, let's look at whether Danaher is worth buying now or not.
Source Fool.com